Age: 3.0
Sex: M
Vaccine: HIBV, DTP, HIBV
Symptoms: Drug toxicity, Hypersensitivity, Injury, Lymphadenitis, Mental retardation severity unspecified
Clinical narrative: Information has been received regarding a case in litigation concerning a minor black male, who on 21-OCT-1991 was unable to say any words that were understandable in developmental screen, and who had a history of constipation, who was exposed to high levels of mercury from thimerosal through exposure to unspecified products. The patient was exposed to mercury from continually inhaling and ingesting industry mercury emissions from fossil fuel driven power plants. It was alleged that the mercury included in thimerosal laden products and power plan emissions together caused the patient to suffer serious and permanent neurological injuries. The patient's exposure to airborne mercury vapor and  mercury in the environment through inhalation, the food chain, and other sources contributed to the cumulative mercury toxicity and was a substantial factor causing neurological damage. It was reported that the patient had a heightened vulnerability to suffer neurological injuries from industrial mercury as a direct result of thimerosal exposure. Subsequently the patient experienced serious and permanent neurological damages which included past and future mental, intellectual, developmental and neurological incapacity, and associate learning disorders, disabilities and impairments. Follow up information from a physician via medical records indicated that the patient was vaccinated with a dose of hib conj vaccine (manufacturer unknown) on 05-MAY-1992. Concomitant therapy administered on the same day included tuberculin purified protein derivative. On 07-MAR-1996 the patient was seen in a physician's office and it was noted that he was go to a special school for autism. On 07-MAY-1996 the patient was evaluated and it was reported that he had a number of atypical behaviors. His eye contact was poor and his attention to speech was quite variable. The patient also frequently placed his hands over his ears when he was screaming during tantrums. His tantrumed severely when his routing had changed. The diagnostic impression was an autistic disorder and moderate mental retardation. On 30-MAR-1998 the patient was seen in a physician's office and was noted to have attention deficit hyperactivity disorder and to be autistic. The patient was placed on Ritalin. On 04-JUN-1998 the patient was evaluated as his mother reported a number of concerns with his behavior. Her primary concerns included temper tantrums, physical aggression, food selectivity/refusal, and overactivity. The recommendation was for some short term parent training in behavior management strategies. On 30-MAR-2000 the patient was evaluated at a clinic on account of "autism". The principal concern seemed to be tantrums and other behavioral issues. The assessment from the evaluation indicated that the diagnosis of pervasive developmental disorder would apply, though it was not severe in all regards, for example, his social interaction and ability to do such things as naming, recitation of alphabet, following instructions, etc... It was reported that there were no suggestions of an etiologic diagnosis, but diagnostic studies would be done in order to rule out certain concerns. Upon internal review the patient's pervasive developmental disorder was considered to be an other important medical event (OMIC). At the time of this report the patient had not recovered. The patient's vaccination history included a first, second, third, fourth and fifth dose of DTP on 11-APR-1989, 06-JUN-1989, 11-AUG-1989, 29-AUG-1990, and 18-AUG-1994, respectively, a first, second, third, and fourth dose of IPV on 11-APR-1989, 06-JUN-1989, 29-AUG-1990, and 02-SEP-1994, respectively, a first and second dose of MMR II on 16-MAY-1990 and 10-AUG-1994, respectively, and a first, second, and third dose of hepatitis B virus vaccine rHBsAg (manufacturer unknown) on 28-AUG-1995, 21-SEP-1995, and 07-MAR-1996, respectively. Follow up information received on 12-SEP-2006 contained the following adverse experiences: scabies (28-APR-1999), wheezing (12-MAY-1999), herpetic gingivostomatitis (13-NOV-2000), lymphadenitis (27-NOV-2000), coughing (16-MAY-2001), stomach pain (08-OCT-2001), constipation (08-OCT-2001), laceration to right arm (06-JAN-2002), upper respiratory infection (18-JAN-2002), and allergies (24-MAR-2003). No further information is available. All available medical records will be provided upon request.